Product image of Heparină Sodică Panpharma (Heparin Sodium) supplied by GNH India

Heparină Sodică Panpharma

Active Ingredient:
Heparin Sodium
Origin:
EU

Heparină Sodică Panpharma (Heparin Sodium)

Heparină Sodică Panpharma is an injectable solution containing the anticoagulant heparin sodium. The product is supplied in a sterile liquid form for intravenous administration and is marketed in the European Union. It is a prescription‑only medication used to inhibit clot formation by enhancing antithrombin III activity, targeting thrombin and factor Xa in the coagulation cascade.

Manufacturer / TM Owner

Panpharma

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Heparină Sodică Panpharma is employed in clinical settings to prevent and treat thromboembolic conditions. It is indicated for several high‑risk situations where clot formation must be controlled.

  • Prevention and treatment of deep vein thrombosis (DVT)
  • Prevention and treatment of pulmonary embolism (PE)
  • Prophylaxis of thromboembolic events during major surgery or orthopedic procedures
  • Management of acute coronary syndromes, including unstable angina and myocardial infarction
  • Use in patients requiring rapid anticoagulation during interventional cardiology procedures

Side Effects

Heparină Sodică Panpharma may cause a range of adverse reactions, most of which are related to its anticoagulant activity. Patients should be monitored for both common and serious events.

Common

  • Minor bleeding at injection site
  • Nosebleeds (epistaxis)
  • Hematuria (blood in urine)
  • Gastrointestinal irritation or mild abdominal pain
  • Elevated liver enzymes (transient)

Serious

  • Major hemorrhage (intracranial, gastrointestinal, or surgical site)
  • Heparin‑induced thrombocytopenia (HIT)
  • Allergic reactions, including anaphylaxis
  • Spontaneous spinal or epidural hematoma

Precautions & Warnings

Before initiating Heparină Sodică Panpharma, clinicians should assess individual risk factors and monitor patients closely. Specific considerations include:

  • Baseline complete blood count and coagulation parameters (aPTT, PT/INR)
  • History of bleeding disorders, recent surgery, or trauma
  • Renal or hepatic impairment may alter drug clearance
  • Pregnancy category B; use only if benefit outweighs risk
  • Caution in patients with uncontrolled hypertension
  • Avoid concurrent use with other anticoagulants unless specifically indicated

Avoid Interactions

Heparină Sodică Panpharma can interact with several medications, affecting bleeding risk or anticoagulant efficacy. Interaction management is essential.

Avoid

  • Concurrent use of other anticoagulants (e.g., warfarin, direct oral anticoagulants) without careful monitoring
  • Thrombolytic agents (e.g., alteplase, streptokinase)
  • High‑dose aspirin or non‑steroidal anti‑inflammatory drugs (NSAIDs)

Use with caution

  • Antiplatelet drugs (e.g., clopidogrel, ticagrelor)
  • Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents
  • Glycoprotein IIb/IIIa inhibitors
  • Certain antibiotics (e.g., vancomycin) that may potentiate bleeding

Frequently Asked Questions

Heparină Sodică Panpharma contains heparin sodium, which enhances the activity of antithrombin III. This leads to inhibition of thrombin (factor IIa) and factor Xa, reducing the conversion of fibrinogen to fibrin and thereby preventing clot formation.

It is commonly prescribed for prevention and treatment of deep vein thrombosis, pulmonary embolism, prophylaxis of thromboembolic events during surgery, and management of acute coronary syndromes such as unstable angina and myocardial infarction.

The medication is supplied as an injectable solution and is administered intravenously under medical supervision, typically in a hospital or clinical setting.

Patients usually require baseline and periodic monitoring of activated partial thromboplastin time (aPTT), platelet counts, and complete blood count to assess anticoagulant effect and detect potential complications such as heparin‑induced thrombocytopenia.

Heparin sodium is classified as pregnancy category B, indicating that animal studies have not shown risk to the fetus and there are no adequate human studies. It may be used if the potential benefit justifies the potential risk.

Common side effects include minor bleeding at the injection site, nosebleeds, hematuria, mild abdominal discomfort, and transient elevations in liver enzymes.

Serious reactions include major hemorrhage (e.g., intracranial or gastrointestinal bleeding), heparin‑induced thrombocytopenia, severe allergic reactions such as anaphylaxis, and spinal or epidural hematoma.

Concurrent use with other anticoagulants should generally be avoided unless specifically directed and closely monitored, due to an increased risk of severe bleeding.

There are no specific dietary restrictions, but patients should avoid excessive intake of vitamin K–rich foods if they are also taking vitamin K antagonists, and should discuss any supplements with their healthcare provider.

Heparin therapy is typically administered in a controlled clinical environment; missed doses should be addressed by the treating physician, who may adjust the dosing schedule or provide an alternative anticoagulation strategy.

HIT is suspected when platelet counts drop by more than 50% from baseline after 5–10 days of heparin exposure, accompanied by new thrombosis. Laboratory testing for platelet factor 4 antibodies confirms the diagnosis.

Patients with severe renal impairment may require dose adjustments and closer monitoring, as reduced clearance can increase the risk of bleeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Heparin Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT